TCL Archive Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials. October 15, 2004
TCL Archive DCPC Board Okays Start of Low Fat High Risk Breast Cancer Study, Delays Stage 2 Trial February 1, 1985
TCL Archive In Brief: Cooperative Group Investigators Treat 10 For Every Patient In Protocols – Holland October 31, 1975